NCT00600158

Brief Summary

Epidural local anesthetics are the gold standard for shortening duration of bowel dysfunction after bowel surgery. Previous studies suggest that their effect may be in part a result of actions of the local anesthetic outside the epidural space. If local anesthetics could be administered intravenously instead, this might be a safer, easier and less expensive approach. Therefore, this trial will compare the effect on bowel function recovery of intravenous local anesthetics with those administered epidurally.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2005

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 24, 2008

Completed
Last Updated

January 24, 2008

Status Verified

January 1, 2008

Enrollment Period

1.2 years

First QC Date

January 11, 2008

Last Update Submit

January 23, 2008

Conditions

Keywords

colectomy

Outcome Measures

Primary Outcomes (1)

  • time from end of surgery to first sign of bowel function (stool or flatus)

    follow-up after surgery

Secondary Outcomes (3)

  • Postoperative pain and opiate consumption

    post-surgery follow-up

  • postoperative nausea and antiemetic use

    post-surgery follow-up

  • duration of hospital stay

    post-surgery follow-up

Study Arms (2)

2

EXPERIMENTAL

lidocaine intravenously

Drug: lidocaine

1

ACTIVE COMPARATOR

epidural local anesthetic

Drug: bupivacaine with hydromorphone

Interventions

bupivacaine 0.125% with hydromorphone 6 mcg/ml epidurally at 10 ml/h

1

lidocaine 2 mg/min intravenously (or 3 mg/kg in patients \> 70 kg)

2

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent
  • Scheduled for colon tumor resection.
  • American Society of Anesthesiologists (ASA) physical classification classes I, II, and III.

You may not qualify if:

  • Age \<18 or \>75 years
  • Allergy to local anesthetics
  • Severe cardiovascular disease (myocardial infarction within 6 months, profoundly decreased left ventricular function (ejection fraction \<40%), or high-grade arrhythmias) or liver disease (known AST or ALT or bilirubin \>2.5 times the upper limit of normal)
  • Systemic corticosteroid use
  • Chronic use of opiates
  • Unwillingness or contraindication to epidural analgesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia

Charlottesville, Virginia, 22908, United States

Location

Related Publications (1)

  • Swenson BR, Gottschalk A, Wells LT, Rowlingson JC, Thompson PW, Barclay M, Sawyer RG, Friel CM, Foley E, Durieux ME. Intravenous lidocaine is as effective as epidural bupivacaine in reducing ileus duration, hospital stay, and pain after open colon resection: a randomized clinical trial. Reg Anesth Pain Med. 2010 Jul-Aug;35(4):370-6. doi: 10.1097/AAP.0b013e3181e8d5da.

MeSH Terms

Interventions

BupivacaineHydromorphoneLidocaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAcetanilides

Study Officials

  • Marcel E Durieux, MD PhD

    University of Virginia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 11, 2008

First Posted

January 24, 2008

Study Start

April 1, 2005

Primary Completion

July 1, 2006

Study Completion

July 1, 2006

Last Updated

January 24, 2008

Record last verified: 2008-01

Locations